Article
High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia.
Nature communications - 17 Jan 2024
Saffari Afshin, Brechmann Barbara, Böger Cedric, Saber Wardiya Afshar, Jumo Hellen, Whye Dosh, Wood Delaney, Wahlster Lara, Alecu Julian E, Ziegler Marvin, Scheffold Marlene, Winden Kellen, Hubbs Jed, Buttermore Elizabeth D, Barrett Lee, Borner Georg H H, Davies Alexandra K, Ebrahimi-Fakhari Darius, Sahin Mustafa
Abstract excerpt
Unbiased phenotypic screens in patient-relevant disease models offer the potential to detect therapeutic targets for rare diseases. In this study, we developed a high-throughput screening assay to identify molecules that correct aberrant protein trafficking in adapter protein complex 4 (AP-4) deficiency, a rare but prototypical form of childhood-onset hereditary spastic paraplegia characterized by mislocalization...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
